Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
11/04/2010 | US20100279931 Insulin Derivative |
11/04/2010 | US20100279930 Human pancreatic polypeptide (hpp) analogues and their effects on feeding behaviour |
11/04/2010 | US20100279929 Novel bacillus thuringiensis gene with coleopteran activity |
11/04/2010 | US20100279928 Sldlr in viral hepatitis |
11/04/2010 | US20100279927 Growth factor complex |
11/04/2010 | US20100279926 Compositions and Methods for Treating Atherosclerosis |
11/04/2010 | US20100279924 Peptides and peptide derivatives as well as pharmaceutical compositions containing the same |
11/04/2010 | US20100279923 Therapeutic application of kazal-type serine protease inhibitors |
11/04/2010 | US20100279918 Chimeric Constructs Between Cancer-Homing Peptides and Cell-Penetrating Peptides Coupled to Anticancer Drugs and/or Diagnostic Agent/Agents |
11/04/2010 | US20100279432 Indirectly labelled assay conjugates and methods of preparing and using same |
11/04/2010 | US20100279406 Alteration of tumor growth using zinc finger proteins |
11/04/2010 | US20100279382 Compositions and methods for quantification of serum glycoproteins |
11/04/2010 | US20100279380 Methods for Degrading Toxic Compounds |
11/04/2010 | US20100279350 C-type lectin polypeptide, polynucleotide and methods of making and use thereof |
11/04/2010 | US20100279349 Nucleic acids encoding two-component sensing and regulatory proteins, antimicrobial proteins and uses therefor |
11/04/2010 | US20100279333 Methods of treatment with antibodies to a chemokine expressed in inflamed adenoid |
11/04/2010 | US20100279318 Method of identifying transmembrane protein-interacting compounds |
11/04/2010 | US20100279313 Novel secreted immunomodulatory proteins and uses thereof |
11/04/2010 | US20100278937 Compositions and methods to prevent and/or treat cancer with pa-card |
11/04/2010 | US20100278892 High affinity metal-oxide binding peptides with reversible binding |
11/04/2010 | US20100278871 Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein |
11/04/2010 | US20100278861 Methods and compositions for predicting emergence and expansion of drug resistant strains of influenza virus |
11/04/2010 | US20100278857 Dendritic Cell Binding Proteins and Uses Thereof |
11/04/2010 | US20100278856 BoNT/A PEPTIDES AND METHODSOF PREDICTING AND REDUCING IMMUNORESISTANCE TO BOTULINUM TOXIN THERAPY |
11/04/2010 | US20100278854 Chlamydia antigens |
11/04/2010 | US20100278853 Constrained hiv v3 loop peptides as novel immunogens and receptor antagonists |
11/04/2010 | US20100278852 Antibodies against and methods for producing vaccines for respiratory syncytial virus |
11/04/2010 | US20100278850 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
11/04/2010 | US20100278848 Tumor antigen bfy3 for prevention and/or treatment of cancer |
11/04/2010 | US20100278840 Methods for treating rheumatoid arthritis using il-17 antagonists |
11/04/2010 | US20100278831 Nogo Receptor-Mediated Blockade of Axonal Growth |
11/04/2010 | US20100278830 Methods and systems for multi-antibody therapies |
11/04/2010 | US20100278827 Concatameric immunoadhesion molecule |
11/04/2010 | US20100278826 Designer Ubiquitin Ligases For Regulation Of Intracellular Pathogenic Proteins |
11/04/2010 | US20100278825 Mammalian Receptor Proteins; Related Reagents and Methods |
11/04/2010 | US20100278821 N-cadherin: target for cancer diagnosis and therapy |
11/04/2010 | US20100278819 Streptococcus pneumoniae vaccines |
11/04/2010 | US20100278792 Method of enhancing proliferation and/or hematopoietic differentiation of stem cells |
11/04/2010 | US20100278791 Adeno-associated virus serotype i nucleic acid sequences, vectors and host cells containing same |
11/04/2010 | US20100278774 Fusion molecules and il-15 variants |
11/04/2010 | US20100278773 Chimeric flavivirus vaccines |
11/04/2010 | US20100278740 Streptococcus pneumoniae proteins and nucleic acid molecules |
11/04/2010 | US20100275502 Rodenticide |
11/04/2010 | DE19851415B4 Mutanter Transaktivator The mutant transactivator |
11/04/2010 | CA2796563A1 Immunoreactive ehrlichia p120/p140 epitopes and uses thereof |
11/04/2010 | CA2768045A1 Sensor for protein-type electron mediator |
11/04/2010 | CA2764432A1 Anti-il-3ra antibody for use in treatment of blood tumor |
11/04/2010 | CA2760525A1 Toll-like receptor 3 antagonists |
11/04/2010 | CA2760446A1 Inducible interleukin-12 |
11/04/2010 | CA2760429A1 Plants having enhanced yield-related traits and a method for making the same |
11/04/2010 | CA2760392A1 Influenza vaccine |
11/04/2010 | CA2760275A1 Modification of the genome of a lytic bacteriophage by immobilizing said bacteriophage in the host bacterium thereof |
11/04/2010 | CA2760042A1 Compositions and methods for modulating stem cells and uses thereof |
11/04/2010 | CA2759911A1 Protein electron mediator |
11/04/2010 | CA2759797A1 A novel subtype of clostridium botulinum neurotoxin type a and uses thereof |
11/04/2010 | CA2759792A1 Improved antibodies immunoreactive with heregulin-coupled her3 |
11/04/2010 | CA2759468A1 Insulinotropic peptide synthesis using solid and solution phase combination techniques |
11/04/2010 | CA2759424A1 Collagen peptide composition having good ability to enter the blood and food or beverage containing the same |
11/04/2010 | CA2759400A1 Chimeric factor h binding proteins (fhbp) and methods of use |
11/04/2010 | CA2757638A1 Erg monoclonal antibodies |
11/04/2010 | CA2756760A1 Compositions and methods for screening and using compounds antagonizing spore-surface interactions |
11/03/2010 | EP2246430A1 Anti-adam-15 antibodies and utilization of the same |
11/03/2010 | EP2246421A1 Glucose-induced inactivation/degradation resistance transporter gene and use of the same |
11/03/2010 | EP2246367A1 Low-molecular-weight substance derived from maitake mushroom and having immunostimulating activity and anti-tumor activity |
11/03/2010 | EP2246362A2 Polymer conjugates of mutated neublastin |
11/03/2010 | EP2246361A1 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis |
11/03/2010 | EP2246360A1 Compositions for the treatment of gastrointestinal disorders |
11/03/2010 | EP2246064A1 Recombinant ganoderma lucidium immunomodulatory protein (rlz-8) and uses thereof |
11/03/2010 | EP2245571A2 Methods for determining correlated residues in a protein or other biopolymer using molecular dynamics |
11/03/2010 | EP2245173A2 Thermophilic and thermoacidophilic glycosylation genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods |
11/03/2010 | EP2245171A2 Cell lines and methods for making and using them |
11/03/2010 | EP2245170A1 Zea mays aba signaling genes and methods of use |
11/03/2010 | EP2245168A2 Plants having enhanced yield-related traits and a method for making the same |
11/03/2010 | EP2245060A1 Liquid enzyme composition |
11/03/2010 | EP2245059A1 Cd4+ t-cells with cytolytic properties |
11/03/2010 | EP2245058A2 Cell lines expressing gaba receptor and methods using them |
11/03/2010 | EP2245057A1 Novel cell lines expressing enac and methods using them |
11/03/2010 | EP2245056A2 Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage |
11/03/2010 | EP2245055A2 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics |
11/03/2010 | EP2245054A1 Muteins of tear lipocalin having affinity to human c-met receptor tyrosine kinase and methods for obtaining the same |
11/03/2010 | EP2245053A1 Identification of a novel cysteine-rich cell penetrating peptide |
11/03/2010 | EP2245052A2 Selective exosite inhibition of papp-a activity against igfbp-4 |
11/03/2010 | EP2245051A1 Fusion polypeptides comprising a shbg dimerization component and uses thereof |
11/03/2010 | EP2245050A2 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
11/03/2010 | EP2245049A2 Vaccines and diagnostics for the ehrlichioses |
11/03/2010 | EP2245048A2 Meningococcal fhbp polypeptides |
11/03/2010 | EP2245047A1 Hydrophobic modified pres-derived peptides of hepatitis b virus (hbv) and their use as vehicles for the specific delivery of compounds to the liver |
11/03/2010 | EP2245046A2 Novel cell lines expressing nav and methods using them |
11/03/2010 | EP2245044A2 Purification of non-glycosylated proteins |
11/03/2010 | EP2245043A1 A method of purifying a peptide |
11/03/2010 | EP2244739A1 Selenium containing modifying agents and conjugates |
11/03/2010 | EP2244732A1 A truncated form of the hiv p17 protein |
11/03/2010 | EP2244725A1 Novel peptides and protein and uses thereof |
11/03/2010 | EP2244724A1 Use of peptides for promoting wound healing |
11/03/2010 | EP2244723A2 Compositions and methods for treating diseases associated with angiogenesis and inflammation |
11/03/2010 | EP2244722A1 Treatment of microbial infections |
11/03/2010 | EP2244718A2 Peptides having binding affinity to an antibody which recognizes an epitope on an 1 loop 2 or 2 loop 1 of an adrenoreceptor |
11/03/2010 | EP2244563A1 Methods, compositions, and systems for production of recombinant spider silk polypeptides |
11/03/2010 | EP1841790B1 Ephb receptor-binding peptides |
11/03/2010 | EP1741792B1 Novel ligand of g-protein-conjugated receptor protein and use thereof |